1. "Clinical Lymphoma, Myeloma and Leukemia"
Formats
  1. Meeting Abstract (271)
  2. Journal Article (69)
  3. Review (7)
  4. Conference Paper (1)
  5. Guidelines (1)
  6. Research Letter (1)
Groups
  1. Hematologic Malignancies, Division of (298)
  2. Department of Medicine (295)
  3. Center for Hematologic Malignancies (277)
  4. Adult Leukemia (113)
  5. Myeloma (77)
  6. Hematologic Malignancies Research (71)

More Groups

People
  1. Saad Usmani (56)
  2. Sergio Giralt (48)
  3. Alexander Lesokhin (44)
  4. Michael Mauro (43)
  5. Heather Landau (42)
  6. Hani Hassoun (40)

More People

Years
  1. 2024 (1)
  2. 2023 (79)
  3. 2022 (64)
  4. 2021 (40)
  5. 2020 (29)
  6. 2019 (38)

More Years

Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (350)
Publishers
  1. Elsevier Inc. (350)

Results (350)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeted conditioning with anti-CD45 iodine ((131)I) apamistamab [Iomab-B] leads to high rates of transplantation and engraftment in older patients with active, relapsed, or refractory (rel/ref) AML: Preliminary midpoint results from the prospective, randomized phase 3 SIERRA trial
    Meeting Abstract

    Gyurkocza, B.; Nath, R.; Stiff, P.; Agura, E.; Litzow, M.; Tomlinson, B.; Choe, H.; Abhyankar, S.; Seropian, S.; Chen, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Ivosidenib (IVO) prior to hematopoietic cell transplant (HCT) for patients with IDH1-mutant relapsed or refractory acute myeloid leukemia (R/R AML) who cannot tolerate intensive chemotherapy (IC)
    Meeting Abstract

    DiNardo, C. D.; Stein, E. M.; Pigneux, A.; Altman, J. K.; Collins, R.; Erba, H. P.; Watts, J. M.; Uy, G. L.; Wu, B.; Choe, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Treatment of newly diagnosed classical Hodgkin lymphoma
    Meeting Abstract

    Straus, D. J.
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Next questions - Classical Hodgkin lymphoma (cHL)
    Meeting Abstract

    Straus, D. J.
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Burkitt lymphoma - Subtypes, pathogenesis, and treatment strategies
    Meeting Abstract

    Noy, A.
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Intensive induction therapy compared with CHOP for hepatosplenic T-cell lymphoma
    Journal Article

    Klebaner, D.; Koura, D.; Tzachanis, D.; Ball, E. D.; Horwitz, S.; Goodman, A. M.
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Ibrutinib-associated arthralgias/myalgias in patients with chronic lymphocytic leukemia: Incidence and impact on clinical outcomes
    Journal Article

    Rhodes, J. M.; LoRe, V. A. 3rd; Mato, A. R.; Chong, E. A.; Barrientos, J. C.; Gerson, J. N.; Barta, S. K.; Landsburg, D. J.; Nasta, S. D.; Svoboda, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Vitiligo following autologous hematopoietic stem cell transplantation
    Journal Article

    Nguyen, J.; Singh, N.; Afifi, S.; Giralt, S.; Lacouture, M. E.; Busam, K. J.; Hassoun, H.
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Prognostic testing and treatment patterns in chronic lymphocytic leukemia in the era of novel targeted therapies: Results from the informCLL registry
    Journal Article

    Mato, A. R.; Barrientos, J. C.; Ghosh, N.; Pagel, J. M.; Brander, D. M.; Gutierrez, M.; Kadish, K.; Tomlinson, B.; Iyengar, R.; Ipe, D.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Daratumumab-based regimen in treating clonal plasma cell neoplasms in solid organ transplant recipients
    Journal Article

    Chaulagain, C. P.; Diacovo, J. M.; Elson, L.; Comenzo, R. L.; Samaras, C.; Anwer, F.; Khouri, J.; Landau, H.; Valent, J.
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save